Carboprost Alembic for Postpartum hemorrhage refractory to oxytocin
Quick answer: Carboprost Alembic is used for Postpartum hemorrhage refractory to oxytocin as part of a prostaglandin f2-alpha analog (uterotonic) treatment regimen. Synthetic 15-methyl prostaglandin F2-alpha that stimulates myometrial contractions via prostaglandin receptors The specific dosing for Postpartum hemorrhage refractory to oxytocin is determined by your prescriber based on individual factors.
Why is Carboprost Alembic used for Postpartum hemorrhage refractory to oxytocin?
Carboprost Alembic belongs to the Prostaglandin F2-alpha analog (uterotonic) class. Synthetic 15-methyl prostaglandin F2-alpha that stimulates myometrial contractions via prostaglandin receptors This action makes it useful for treating or managing Postpartum hemorrhage refractory to oxytocin in patients for whom this approach is clinically appropriate.
It is one of several treatment options. Whether Carboprost Alembic is the right choice for a specific patient depends on the type and severity of Postpartum hemorrhage refractory to oxytocin, response to previous treatments, individual risk factors, and clinical guidelines.
Typical dosing for Postpartum hemorrhage refractory to oxytocin
Common adult dosing range: 250 mcg IM, may repeat every 15-90 min, max 2 mg total. The actual dose for Postpartum hemorrhage refractory to oxytocin depends on:
- Severity of the condition
- Patient's age, weight, and organ function
- Other medications being taken
- Treatment response and tolerability
For complete dosing details, see the Carboprost Alembic medicine page.
What to expect
Carboprost Alembic treatment for Postpartum hemorrhage refractory to oxytocin typically involves:
- Onset of effect: varies by indication and dose — some effects are immediate, others take days to weeks
- Treatment duration: some courses are short-term, others are long-term or lifelong depending on Postpartum hemorrhage refractory to oxytocin
- Monitoring: follow-up visits to assess response and adjust dosing
- Side-effect awareness: learning what to expect and what warrants medical attention
Alternatives to consider
If Carboprost Alembic is not appropriate or not tolerated, alternatives within the same class or different therapeutic classes may be considered. See all Prostaglandin F2-alpha analog (uterotonic) for related options.
When to talk to your doctor
Discuss with your prescriber if you experience:
- Inadequate symptom control on Carboprost Alembic
- Side effects affecting daily life
- New medications or supplements that may interact
- Pregnancy planning or pregnancy
- Major changes in health status
Related information
Carboprost Alembic full prescribing information · All Prostaglandin F2-alpha analog (uterotonic) alternatives
Frequently asked questions
How effective is Carboprost Alembic for Postpartum hemorrhage refractory to oxytocin?
Effectiveness varies by individual response, dose, and severity. Carboprost Alembic is one of several treatment options for Postpartum hemorrhage refractory to oxytocin, supported by clinical evidence within the prostaglandin f2-alpha analog (uterotonic) class. Discuss expected response with your prescriber.
How long do I need to take Carboprost Alembic for Postpartum hemorrhage refractory to oxytocin?
Treatment duration depends on the nature of Postpartum hemorrhage refractory to oxytocin — some treatments are short-term, others long-term or lifelong. Never stop on your own; discontinuation requires clinical guidance to avoid relapse or rebound effects.
What are the main side effects of Carboprost Alembic when used for Postpartum hemorrhage refractory to oxytocin?
Common and serious side effects are class-related and substance-specific. See the full medicine page for the complete profile. Report any unexpected effects to your prescriber.
Are there alternatives to Carboprost Alembic for Postpartum hemorrhage refractory to oxytocin?
Yes. Multiple medicines and non-drug options exist for Postpartum hemorrhage refractory to oxytocin. Alternatives within the prostaglandin f2-alpha analog (uterotonic) class share mechanisms; other classes may offer different approaches. Discuss with your clinician.
Last reviewed: by iMedic Medical Editorial Team. Our editorial process.